Cargando…
Validity of Diagnosis Code–Based Claims to Identify Pulmonary NTM Disease in Bronchiectasis Patients
Nontuberculous mycobacteria infection is increasing in incidence and can lead to chronic, debilitating pulmonary disease. We investigated the accuracy of diagnosis code–based nontuberculous mycobacteria lung disease claims among Medicare beneficiaries in the United States. We observed that these cla...
Autores principales: | Ku, Jennifer H., Henkle, Emily M., Carlson, Kathleen F., Marino, Miguel, Winthrop, Kevin L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920682/ https://www.ncbi.nlm.nih.gov/pubmed/33622467 http://dx.doi.org/10.3201/eid2703.203124 |
Ejemplares similares
-
192. Tolerability Outcomes of Multi-drug Antibiotic Treatment for Pulmonary Nontuberculous Mycobacterial Disease due to Mycobacterium avium Complex in U.S. Medicare Beneficiaries with Bronchiectasis
por: Ku, Jennifer, et al.
Publicado: (2021) -
Comparative safety of inhaled corticosteroids and macrolides in Medicare enrolees with bronchiectasis
por: Henkle, Emily, et al.
Publicado: (2022) -
1365. Self-Reported Impacts of COVID-19 Pandemic on Patients with Bronchiectasis and Nontuberculous Mycobacterium Pulmonary Infections: Healthcare Avoidance and Other Impacts Across Delta and Omicron Waves
por: Miller, Haley, et al.
Publicado: (2023) -
1375. Laboratory Abnormalities Among Patients with Pulmonary Mycobacterium avium Complex Infections
por: Varley, Cara D, et al.
Publicado: (2019) -
Whole genome sequencing of Nontuberculous Mycobacterium (NTM) isolates from sputum specimens of co-habiting patients with NTM pulmonary disease and NTM isolates from their environment
por: Yoon, Jung-Ki, et al.
Publicado: (2020)